Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NORBIT – Advanced negotiations regarding a NOK 115 million contract
-
Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 million
-
TextMagic AS 2025 12 months consolidated unaudited interim report
-
ASML publishes 2025 Annual Reports
-
Start of Day Message
-
Vow ASA: Record Q4 revenues and strategy revision concluded
-
KALDVIK AS (KLDVK): Q4 2025 Quarterly Update
-
Bigbank AS Results for January 2026
-
Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030
-
Martela Corporation’s Financial Statements 1 January – 31 December 2025
-
Navatar Launches AI-Powered CRM Operating Model On Salesforce for Alternative Asset Managers
-
FLSmidth: Transactions under share buy-back programme
-
Abbott Cooper PLLC Investigates Potential Breaches of Fiduciary Duty by MarketWise, Inc. Board of Directors
-
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Abbott Cooper PLLC Investigates Potential Breaches of Fiduciary Duty by Lee Enterprises, Incorporated Board of Directors
-
Intuitive Machines Announces Date for Fourth Quarter, Full-Year 2025 Financial Results, and Post-Lanteris Space Systems Acquisition Conference Call
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Next Point Advises Endodontic Specialties of NEPA on Practice Transition
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Snowflake Inc. (SNOW) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
-
Claritev Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
-
Camping World Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
-
MOZAYYX Acquisition Corp. Announces the Pricing of Upsized $261,000,000 Initial Public Offering
-
Seligra, Valencia's Leading Bespoke Tailoring House, Expands to Madrid After Six Decades in Valencia
-
Seligra, Valencia's Leading Bespoke Tailoring House, Expands to Madrid After Six Decades in Valencia
-
Alkane Advances Near-Mine Kendal Deposit with High Grade Antimony-Gold Intercepts at Costerfield
-
PONY AI Inc. Robotaxis Deliver Strong Chinese New Year Holiday Performance with Record Paid Orders in Shenzhen
-
Western Announces Ratification of La-kwa sa muqw Forestry Limited Partnership and United Steelworkers Agreement
-
Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
-
CORRECTED PRESS RELEASE: Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
-
Saputo USA Recalls Great Value Cottage Cheese Because of Possible Health Risk
-
Pulse Seismic Inc. Reports 2025 Financial Results and Declares Regular and Special Dividends
-
PennantPark Floating Rate Capital Ltd. Completes the Reset of a $356.5 Million Securitization, Substantially Reducing Borrowing Costs
-
PHX Energy Announces a Special Dividend and Record Fourth Quarter and Annual Revenue Supported by Strong RSS Activity

